Effects of tilmicosin treatment on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract disease
- 1 May 2000
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 61 (5) , 525-529
- https://doi.org/10.2460/ajvr.2000.61.525
Abstract
Objective—To determine the effect of tilmicosin treatment on number ofPasteurella haemolytica(PH) organisms in nasal secretion specimens of calves with respiratory tract disease.Animals—206 British mixed-breed beef calves, 2 to 5 months old.Procedure—In 2 separate studies of outbreaks, calves (study 1, n = 101; study 2, n = 105) that developed respiratory tract disease after transport to a feedlot were treated with tilmicosin. Nasal secretion specimens were examined for PH organisms to determine the status of colonization.Results—In both studies, PH serotypes A1 and A6 were isolated. In study 1, tilmicosin treatment eliminated or markedly reduced the number of PH organisms in calves on days 1, 4, and 5 after treatment. In study 2, tilmicosin treatment eliminated PH organisms in calves on days 1, 2, 5, and 6 after treatment.Conclusions and Clinical Relevance—Overall, tilmicosin treatment increased the number of culture-positive calves that became culture-negative and decreased the number of culture-negative calves that became culture-positive for up to 6 days after treatment. Tilmicosin treatment decreased the number of PH organisms in nasal secretion specimens, which indicated that fewer PH organisms were available to infect the lungs or to infect other calves. By reducing colonization, prophylactic use of tilmicosin before transport or at the time of arrival at a feedlot is likely to reduce the incidence of acute respiratory tract disease in calves for the initial several days after arrival, which is the period when they are most susceptible to infectious organisms. (Am J Vet Res2000;61: 525–529)Keywords
This publication has 11 references indexed in Scilit:
- Minimum Inhibitory Concentration Breakpoints and Disk Diffusion Inhibitory Zone Interpretive Criteria for Tilmicosin Susceptibility Testing against Pasteurella Spp. Associated with Bovine Respiratory DiseaseJournal of Veterinary Diagnostic Investigation, 1996
- Efficacy of strategic tilmicosin injection during an outbreak of respiratory disease in housed beef calvesBritish Veterinary Journal, 1995
- Effects of arrival medication with tilmicosin phosphate on health and performance of newly received beef cattle1Journal of Animal Science, 1995
- Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic pasteurella haemolytica isolatesVeterinary Quarterly, 1993
- In‐vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattleAustralian Veterinary Journal, 1993
- Efficacy of tilmicosin in treatment of pulmonary infections in calvesVeterinary Record, 1991
- Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracyclineVeterinary Record, 1991
- Prophylactic medication of feedlot calves with tilmicosinVeterinary Record, 1991
- An evaluation of antibiotic therapy on Pasteurella haemolytica present in the nasopharynx of healthy calvesPreventive Veterinary Medicine, 1989
- Single-dose treatment of neonatal calf pneumonia with the new macrolide antibiotic tilmicosinPublished by Wiley ,1988